Stay updated with breaking news from Christophe Bourdon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
STOCKHOLM, May 9, 2023 /PRNewswire/ -- The Sobi® AGM was convened today on 9 May 2023. At the AGM, the shareholders, in accordance with the proposed resolutions, resolved as follows: Adoption
The shareholders in Swedish Orphan Biovitrum AB Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting , to be held on Tuesday, 9 May 2023 at 15.00 at IVA Konferenscenter, Grev... | March 30, 2023
Adtralza, a biologic that targets and neutralizes the interleukin (IL)-13 cytokine1, is now approved in Europe for adolescents with moderate-to-severe atopic dermatitis.2 NOT FOR DISTRIBUTION
Therapy is for the treatment of adolescents with moderate-to-severe atopic dermatitis - News - PharmaTimes
Positive CHMP opinion recommends extending use of Adtralza (tralokinumab) to adolescents (12-17 years old) in the European Union (EU) Recommendation supported by data from the Phase 3 ECZTRA